Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Mirati Therapeutics
Mirati Therapeutics
3 Companies To Watch For At November’s Society for Immunotherapy of Cancer Meeting
Motley Fool
Wed, 10/9/19 - 10:25 am
SITC
cancer immunotherapy
Autolus Therapeutics
Mirati Therapeutics
Nektar Therapeutics
4 Biotech Stocks With Big Catalysts in September
Motley Fool
Thu, 09/5/19 - 10:14 pm
Amgen
AMG 510
Mirati Therapeutics
MRTX849
Eli Lilly
LOXO-292
Blueprint Me
Pralsetinibdicines
Mirati and Novartis Pair Up to Evaluate Drug Combinations to Target KRAS G12C Mutations
BioSpace
Thu, 07/11/19 - 09:52 am
Mirati Therapeutics
Novartis
KRAS
solid tumors
3 Cancer Stocks Given a Lift by Amgen
Motley Fool
Tue, 06/4/19 - 11:07 am
Amgen
KRAS
AMG 510
Mirati Therapeutics
Array Biopharma
Gilead Sciences
ASCO 2019
Here's Why Mirati Therapeutics Is Surging Today
Motley Fool
Thu, 05/16/19 - 06:42 pm
Mirati Therapeutics
Amgen
KRAS inhibitors
MRTX849
AMG 510
Mirati Therapeutics Announces Positive Results in Immuno-Oncology Combination Trials
CP Wire
Wed, 04/25/18 - 09:55 am
Mirati Therapeutics
Opdivo
checkpoint inhibitors
non-small cell lung cancer
Mirati Therapeutics Announces Positive Results in Immuno-Oncology Combination Trials
Tue, 04/24/18 - 11:17 pm
Mirati Therapeutics
Opdivo
checkpoint inhibitors
non-small cell lung cancer
7 Biopharma Companies That Destroyed Shareholders Last Week
24/7 Wall St
Sun, 06/12/16 - 09:52 pm
ProNai
Adamis Pharmaceuticals
Ocular Therapeutics
Mirati Therapeutics
Immunomedics
Valeant Pharmacueticals
Biogen
This Past Week’s Top 5 Biotech Movers
24/7 Wall St
Sat, 09/12/15 - 01:31 pm
biotech
Akebia Therapeutics
Clovis Oncology
Mirati Therapeutics
Vivus
Vitae
AstraZeneca Oncology Partnerships To Help Recover Sales
Bidness ETC
Tue, 08/25/15 - 09:43 am
AstraZeneca
oncology
Pfizer
Peregrine Pharmaceuticals
Heptares Therapeutics
Mirati Therapeutics
Juno Therapeutics
AstraZeneca plc (ADR) Strikes 2 Immuno-Oncology Deals; Are Its Efforts In The Right Direction?
Bidness, ETC
Fri, 08/7/15 - 10:56 am
immuno-oncology
AstraZeneca
HTL-1071
Heptares Therapeutics
Mirati Therapeutics
MedImmune
AstraZeneca ties up with little Mirati on another PD-L1 combo trial
Fierce Biotech
Thu, 08/6/15 - 08:27 am
AstraZeneca
PD-1 inhibitors
durvalumab
MedImmune
Mirati Therapeutics
Ignyta: Now Public With A Targeted Oncology Pipeline Poised For Success
Seeking Alpha
Mon, 02/24/14 - 09:19 am
Ignyta
oncology
Clovis Oncology
Ariad Pharmaceuticals
Mirati Therapeutics
Tesaro
Puma Biotechnology
Pages
« first
‹ previous
1
2
3